OVARIAN CANCER and US: 23andme

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label 23andme. Show all posts
Showing posts with label 23andme. Show all posts

Thursday, March 22, 2012

InVite Study in Metastatic Breast Cancer/Avastin - 23andMe and Genentech study (U.S.)



InVite Study in Metastatic Breast Cancer - 23andMe



Who is Eligible

  1. Diagnosed with breast cancer by a medical professional
  2. Currently have metastatic (stage IV) or recurrent breast cancer
  3. Treated with bevacizumab (also known as Avastin®) at any point in 2010 and/or 2011*
  4. Live in the United States
  5. Age 18 or older
*If you were treated with bevacizumab (also known as Avastin®) after 2011, and are interested in possible future opportunities to participate, please email
invite-study@23andme.com.

What You Get

  • Convenient and easy opportunity to participate in new type of research
  • Help advance medical research in metastatic breast cancer and its treatment
  • Receive updates about research progress and discoveries
  • Learn about your health and ancestry through FREE access to 23andMe's Personal Genome Service